Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Enzo Biochem (ENZ)

Enzo Biochem (ENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 51,570
  • Shares Outstanding, K 52,244
  • Annual Sales, $ 31,910 K
  • Annual Income, $ -26,080 K
  • EBIT $ -12 M
  • EBITDA $ -11 M
  • 60-Month Beta 0.73
  • Price/Sales 1.65
  • Price/Cash Flow N/A
  • Price/Book 0.93

Options Overview Details

View History
  • Implied Volatility 209.55% ( -18.89%)
  • Historical Volatility 33.22%
  • IV Percentile 47%
  • IV Rank 27.41%
  • IV High 682.03% on 12/12/23
  • IV Low 31.13% on 07/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 32
  • Volume Avg (30-Day) 29
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 637
  • Open Int (30-Day) 581

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9602 +1.02%
on 11/21/24
1.1900 -18.49%
on 10/30/24
-0.1700 (-14.91%)
since 10/21/24
3-Month
0.9602 +1.02%
on 11/21/24
1.1900 -18.49%
on 10/30/24
-0.1400 (-12.61%)
since 08/21/24
52-Week
0.9602 +1.02%
on 11/21/24
1.5000 -35.33%
on 01/03/24
-0.2900 (-23.02%)
since 11/21/23

Most Recent Stories

More News
Enzo Biochem: Fiscal Q3 Earnings Snapshot

Enzo Biochem: Fiscal Q3 Earnings Snapshot

ENZ : 0.9700 (-1.73%)
Enzo Biochem: Fiscal Q2 Earnings Snapshot

Enzo Biochem: Fiscal Q2 Earnings Snapshot

ENZ : 0.9700 (-1.73%)
Enzo Biochem: Fiscal Q1 Earnings Snapshot

Enzo Biochem: Fiscal Q1 Earnings Snapshot

ENZ : 0.9700 (-1.73%)
Enzo Biochem: Fiscal Q3 Earnings Snapshot

Enzo Biochem: Fiscal Q3 Earnings Snapshot

ENZ : 0.9700 (-1.73%)
SHAREHOLDER ALERT: Weiss Law Investigates Enzo Biochem, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Enzo Biochem, Inc....

ENZ : 0.9700 (-1.73%)
LH : 240.17 (+0.98%)
Enzo Biochem: Fiscal Q2 Earnings Snapshot

Enzo Biochem: Fiscal Q2 Earnings Snapshot

ENZ : 0.9700 (-1.73%)
Stocks Slide Before the Open as First Republic Shares Fall Despite Rescue Deal

June S&P 500 futures (ESM23) are trending down -0.68% this morning after three major U.S. benchmark indices rallied on Thursday as 11 of the nation’s biggest banks injected $30 billion in deposits into...

ESM23 : 4,453.35s (+0.61%)
FRC : 3.51 (-43.30%)
ENZ : 0.9700 (-1.73%)
FDX : 295.16 (+2.48%)
UPS : 131.37 (-0.55%)
NVDA : 146.67 (+0.53%)
X : 40.51 (+5.55%)
SRPT : 110.50 (-0.32%)
WBD : 10.23 (+2.81%)
Enzo Biochem: Fiscal Q1 Earnings Snapshot

Enzo Biochem: Fiscal Q1 Earnings Snapshot

ENZ : 0.9700 (-1.73%)
Enzo Biochem to Launch Monkeypox Testing Services this Week

NEW YORK, NY, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company,...

ENZ : 0.9700 (-1.73%)
Enzo Biochem Reports Third Quarter Fiscal 2022 Results and Provides Leadership and Corporate Updates Including Engagement of Jefferies as Financial Advisor

Third quarter revenue of $26.2 million declined sequentially and year over year due to the anticipated waning of COVID-19 volumes and the economic...

ENZ : 0.9700 (-1.73%)

Business Summary

Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo...

See More

Key Turning Points

3rd Resistance Point 1.0664
2nd Resistance Point 1.0432
1st Resistance Point 1.0066
Last Price 0.9700
1st Support Level 0.9468
2nd Support Level 0.9236
3rd Support Level 0.8870

See More

52-Week High 1.5000
Fibonacci 61.8% 1.2938
Fibonacci 50% 1.2301
Fibonacci 38.2% 1.1664
Last Price 0.9700
52-Week Low 0.9602

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar